FI930821L - Bestaemning av maolkomponenter - Google Patents

Bestaemning av maolkomponenter Download PDF

Info

Publication number
FI930821L
FI930821L FI930821A FI930821A FI930821L FI 930821 L FI930821 L FI 930821L FI 930821 A FI930821 A FI 930821A FI 930821 A FI930821 A FI 930821A FI 930821 L FI930821 L FI 930821L
Authority
FI
Finland
Prior art keywords
maolkomponenter
bestaemning
Prior art date
Application number
FI930821A
Other languages
English (en)
Finnish (fi)
Other versions
FI930821A0 (fi
FI930821A7 (fi
Inventor
Robert A Levine
Stephen C Wardlaw
Rodolfo Rodriguez
Judith Britz
Thomas J Mercolino
Original Assignee
Robert A Levine
Stephen C Wardlaw
Becton Dickinson Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Robert A Levine, Stephen C Wardlaw, Becton Dickinson Co filed Critical Robert A Levine
Publication of FI930821A0 publication Critical patent/FI930821A0/fi
Publication of FI930821A7 publication Critical patent/FI930821A7/fi
Publication of FI930821L publication Critical patent/FI930821L/fi

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/537—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
    • G01N33/5375—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody by changing the physical or chemical properties of the medium or immunochemicals, e.g. temperature, density, pH, partitioning
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/537—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
    • G01N33/538—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody by sorbent column, particles or resin strip, i.e. sorbent materials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/829—Liposomes, e.g. encapsulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FI930821A 1992-02-25 1993-02-24 Bestaemning av maolkomponenter FI930821L (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US84197692A 1992-02-25 1992-02-25

Publications (3)

Publication Number Publication Date
FI930821A0 FI930821A0 (fi) 1993-02-24
FI930821A7 FI930821A7 (fi) 1993-08-26
FI930821L true FI930821L (fi) 1993-08-26

Family

ID=25286232

Family Applications (1)

Application Number Title Priority Date Filing Date
FI930821A FI930821L (fi) 1992-02-25 1993-02-24 Bestaemning av maolkomponenter

Country Status (17)

Country Link
US (1) US5593848A (enExample)
EP (1) EP0557595B1 (enExample)
JP (1) JP2925105B2 (enExample)
CN (1) CN1091521A (enExample)
AT (1) ATE155889T1 (enExample)
AU (1) AU662571B2 (enExample)
BR (1) BR9300639A (enExample)
CA (1) CA2090282A1 (enExample)
DE (1) DE69221118T2 (enExample)
DK (1) DK0557595T3 (enExample)
ES (1) ES2106121T3 (enExample)
FI (1) FI930821L (enExample)
GR (1) GR3024970T3 (enExample)
MX (1) MX9300965A (enExample)
NO (1) NO930649L (enExample)
RU (1) RU2116068C1 (enExample)
TW (1) TW246716B (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5342790A (en) * 1992-10-30 1994-08-30 Becton Dickinson And Company Apparatus for indirect fluorescent assay of blood samples
AU4101697A (en) * 1996-11-22 1998-05-28 Robert A. Levine Process for enhancing the aggregation and/or agglutination of erythrocytes prior to centrifugation
CA2253965C (en) * 1997-11-22 2003-01-21 Robert A. Levine Method for the detection, identification, enumeration and confirmation of circulating cancer cells and/or hematologic progenitor cells in whole blood
US6197523B1 (en) 1997-11-24 2001-03-06 Robert A. Levine Method for the detection, identification, enumeration and confirmation of circulating cancer and/or hematologic progenitor cells in whole blood
US6911315B2 (en) * 1997-11-24 2005-06-28 David L. Rimm Method for the detection, identification, enumeration and confirmation of virally infected cells and other epitopically defined cells in whole blood
IL139585A0 (en) * 1998-06-26 2002-02-10 Pfizer Prod Inc Improved process for preparing schiff base adducts of amines with 0-hydroxy aldehydes and compositions of matter based thereon
GB0021303D0 (en) * 2000-08-30 2000-10-18 Medinnova Sf Use
CA2504481A1 (en) * 2002-10-30 2004-05-21 Pointilliste, Inc. Systems for capture and analysis of biological particles and methods using the systems
EP1648299A4 (en) * 2003-07-09 2008-10-22 California Pacific Med Center REMOTE DETERMINATION OF THE DELIVERY OF SUBSTANCES IN CELLS
US7996825B2 (en) * 2003-10-31 2011-08-09 Hewlett-Packard Development Company, L.P. Cross-file inlining by using summaries and global worklist
US20060018911A1 (en) * 2004-01-12 2006-01-26 Dana Ault-Riche Design of therapeutics and therapeutics
CA2720068C (en) 2008-04-02 2013-11-19 Abbott Point Of Care, Inc. Virtual separation of bound and free label in a ligand assay for performing immunoassays of biological fluids, including whole blood
WO2009126505A1 (en) * 2008-04-09 2009-10-15 Abbott Point Of Care, Inc. Method of detecting very low levels of analyte within a thin film fluid sample contained in a thin thickness chamber
FR2965273B1 (fr) * 2010-09-29 2015-07-17 Centre Nat Rech Scient Procede de preparation d'une structure chimique presentant une partition de phases, apte a generer un spectre de fluorescence specifique et ses applications
US9624474B2 (en) 2010-12-01 2017-04-18 Samsung Electronics Co, Ltd. Method of separating target cell in biological sample
CN102788879B (zh) * 2011-05-20 2015-04-01 常州康卫生物技术有限公司 一种生物检测试剂
EP3292221B1 (en) * 2015-05-06 2021-06-23 Seracare Life Sciences Inc. Liposomal preparations for non-invasive-prenatal or cancer screening

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3862303A (en) * 1972-02-02 1975-01-21 Atomic Energy Commission Method for rapid detection and identification of serological factors
US4027660A (en) * 1976-04-02 1977-06-07 Wardlaw Stephen C Material layer volume determination
US4181609A (en) * 1977-12-20 1980-01-01 Levine Robert A Blood constituents testing method
DE3000483A1 (de) * 1979-01-09 1980-07-17 Fuji Photo Film Co Ltd Mikrokapseln fuer immunologische bestimmungen
US4332785A (en) 1980-04-09 1982-06-01 University Patents, Inc. Immunoassay for measurement of reticulocytes, and immunoreactive reagents for use therein
IL64878A (en) * 1982-01-27 1986-01-31 Yissum Res Dev Co Method for detection of and determination of malaria antibodies and malaria antigens in human blood
JPS5984162A (ja) * 1982-11-05 1984-05-15 Toshiba Corp 免疫分析法
US4591570A (en) * 1983-02-02 1986-05-27 Centocor, Inc. Matrix of antibody-coated spots for determination of antigens
JPS6035267A (ja) * 1983-08-05 1985-02-23 Fuji Photo Film Co Ltd 多項目免疫検査法
US5011771A (en) * 1984-04-12 1991-04-30 The General Hospital Corporation Multiepitopic immunometric assay
FR2571498B1 (fr) * 1984-10-04 1988-04-08 Immunotech Sa Procede de separation de cellules utilisant des anticorps et des billes de faible densite
JPS6345563A (ja) * 1986-04-11 1988-02-26 Hitachi Ltd 細胞分析方法
US5001225A (en) * 1986-12-08 1991-03-19 Georgetown University Monoclonal antibodies to a pan-malarial antigen
GB2200448B (en) * 1987-01-23 1991-01-16 Univ London Targetted liposomes and their use in immunoassay
US5017472A (en) * 1987-09-09 1991-05-21 Bankert Richard B Microflotation devices used for immunoassays and cell/molecular fractionation
US4978625A (en) * 1987-10-19 1990-12-18 Becton, Dickinson And Company Fluorescence immunoassay using water insoluble dyes
CA2033010A1 (en) * 1989-12-22 1991-06-23 Rajeev Ramanathan Method for separating components in a mixture
JPH03249561A (ja) * 1990-02-28 1991-11-07 Toshiba Corp 免疫分析試薬

Also Published As

Publication number Publication date
RU2116068C1 (ru) 1998-07-27
FI930821A0 (fi) 1993-02-24
BR9300639A (pt) 1993-08-31
JP2925105B2 (ja) 1999-07-28
JPH0821833A (ja) 1996-01-23
ATE155889T1 (de) 1997-08-15
EP0557595A3 (enExample) 1993-11-10
US5593848A (en) 1997-01-14
NO930649D0 (no) 1993-02-24
EP0557595B1 (en) 1997-07-23
DK0557595T3 (da) 1997-12-29
FI930821A7 (fi) 1993-08-26
CA2090282A1 (en) 1993-08-26
EP0557595A2 (en) 1993-09-01
MX9300965A (es) 1994-08-31
CN1091521A (zh) 1994-08-31
NO930649L (no) 1993-08-26
AU662571B2 (en) 1995-09-07
GR3024970T3 (en) 1998-01-30
AU2983692A (en) 1993-08-26
DE69221118D1 (de) 1997-09-04
DE69221118T2 (de) 1998-02-26
TW246716B (enExample) 1995-05-01
ES2106121T3 (es) 1997-11-01

Similar Documents

Publication Publication Date Title
FI934320L (fi) Foerfarande foer malning av farmaceutiska aemnen
FI934804L (fi) Indirekt fluorescensanalys av blodprov
FI930507L (fi) Insprutningsanordning och -foerfarande foer insprutning av tillsatsaemnen
FI931372A7 (fi) Foerfarande foer behandling av rumsluft foer maenskor
FI930281L (fi) Reaktivering av hydroformyleringskatalysatorer
FI931603A0 (fi) Foerfarande foer framstaellning av bifenylderivat
FI935103L (fi) Foerfarande foer faergning av kontaktlinser
FI935054A0 (fi) Bestaemning av saendningskanal
FI934749L (fi) Foerfarande foer framstaellning av aromatiska brommetylfoereningar
FI930821L (fi) Bestaemning av maolkomponenter
FI925945L (fi) Avlaegsnande av kvicksilver fraon avfallsvatten
FI935168L (fi) Regioselektiv syntes av 4-klor-2-tiofenkarboxylsyra
FI931668A0 (fi) Cellrestprodukter av jaest
FI933192L (fi) Anordning foer kultivering av mikroorganismer
FI934900L (fi) Mellandestillatkompostioner av raoolja
FI934570A0 (fi) Stabileringsapparatur foer utvidgning av en kompressors kurvskara
FI930710A7 (fi) Anordning foer oevervakning av vaetskenivao
FI931110A0 (fi) Flerskiktfolier av kopolyamider
FI935429A0 (fi) Foerfarande foer framstaellning av proteinprodukter foer ljusa pappersbelaeggningar
FI930395L (fi) Foerfarande foer framstaellning av bakverk
FI930384L (fi) Foerfarande foer kontinuerlig framstaellning av vinylaromatkopolymerer
FI932570A7 (fi) Foerfarande foer framstaellning av 2-oxo-1-piperidinylderivat
FI931127A7 (fi) Anordning foer behandling av kortformiga databaerare
FI933297A0 (fi) Kristallisering av groenlut
FI924437L (fi) Roterande tillaeggsanordning foer foerbaettring av wobblerns faongsteffekt